Schroder Investment Management Group Sorrento Therapeutics, Inc. Transaction History

Schroder Investment Management Group

  • $94.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.0 - $4.9 $746,764 - $1.83 Million
-373,382 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.65 - $7.23 $1.59 Million - $2.47 Million
-341,439 Reduced 47.77%
373,382 $1.74 Million
Q3 2021

Nov 12, 2021
SELL
$7.41 - $10.99 $1.06 Million - $1.57 Million
-142,476 Reduced 16.62%
714,821 $5.45 Million
Q2 2021

Aug 13, 2021
BUY
$6.35 - $10.0 $2.71 Million - $4.26 Million
426,059 Added 98.8%
857,297 $8.31 Million
Q1 2021

May 17, 2021
BUY
$7.03 - $16.51 $3.03 Million - $7.12 Million
431,238 New
431,238 $3.57 Million

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email